{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T20:03:57Z","timestamp":1773605037097,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbmt.2017.12.786","type":"journal-article","created":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T10:10:41Z","timestamp":1514196641000},"page":"866-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9473-3632","authenticated-orcid":false,"given":"Maryam","family":"Behfar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Faghihi-Kashani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf Sadat","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardeshir","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Ali","family":"Hamidieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.12.786_bib0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1542\/peds.2009-3078","article-title":"Children as hematopoietic stem cell donors","volume":"125","author":"American Academy of Pediatrics","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/petr.12092","article-title":"Hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen in pediatric patients with Griscelli syndrome type 2","volume":"17","author":"Hamidieh","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0020","first-page":"885","article-title":"Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors","volume":"18","author":"Korbling","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pbc.20708","article-title":"Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors","volume":"46","author":"Pulsipher","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/pbc.20800","article-title":"Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee","volume":"46","author":"Grupp","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"suppl 3","key":"10.1016\/j.bbmt.2017.12.786_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1034\/j.1399-3046.7.s3.10.x","article-title":"Peripheral blood as a stem cell source for hematopoietic cell transplantation in children: is the effort in vein?","volume":"7","author":"Lipton","year":"2003","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0040","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V81.7.1883.1883","article-title":"The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis","volume":"81","author":"Bensinger","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1634\/stemcells.19-2-108","article-title":"Peripheral blood stem cells for allogeneic transplantation: a review","volume":"19","author":"Cutler","year":"2001","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2005-836509","article-title":"Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation","volume":"217","author":"Meisel","year":"2005","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.bmt.1702072","article-title":"Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor","volume":"25","author":"Cavallaro","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0060","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2141.2006.06312.x","article-title":"Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project","volume":"135","author":"Bennett","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0065","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/bmt.2010.2","article-title":"Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations","volume":"45","author":"Shaw","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0070","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3476(96)80129-6","article-title":"Use of minors as bone marrow donors: current attitude and management. A survey of 56 pediatric transplantation centers","volume":"128","author":"Chan","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1365-2141.1997.2393053.x","article-title":"Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers","volume":"98","author":"Watts","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0080","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2741\/2103","article-title":"Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders","volume":"12","author":"Touw","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2165\/00003495-199142020-00009","article-title":"Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions","volume":"42","author":"Hollingshead","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0090","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2165\/00003495-199448050-00007","article-title":"Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia","volume":"48","author":"Frampton","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0095","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice guideline update","volume":"33","author":"Smith","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0100","series-title":"Current uses and outcomes of hematopoietic stem cell transplantation: CIBMTR Summary Slides","author":"Pasquini","year":"2015"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0105","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3324\/haematol.12285","article-title":"Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry","volume":"93","author":"de la Rubia","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bmt.2008.440","article-title":"Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience","volume":"44","author":"Martino","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.bmt.1705722","article-title":"Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project","volume":"40","author":"Tigue","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0120","first-page":"3321","article-title":"Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors","volume":"59","author":"Kawano","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2217\/pmt.12.7","article-title":"Ethnic differences in pain and pain management","volume":"2","author":"Campbell","year":"2012","journal-title":"Pain Manag"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.transci.2013.07.036","article-title":"A rare but severe complication of filgrastim in a healthy donor: splenic rupture","volume":"50","author":"Akyol","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0135","first-page":"Ecr08","article-title":"Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature","volume":"91","author":"Nuamah","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0140","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1378\/chest.120.5.1695","article-title":"Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data","volume":"120","author":"Azoulay","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0145","first-page":"Ecr10","article-title":"Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone","volume":"90","author":"Arimura","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0150","first-page":"Ecr05","article-title":"Severe autoimmune hyperthyroidism after donation of growth factor-primed allogeneic peripheral blood progenitor cells","volume":"89","author":"Kroschinsky","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","article-title":"Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry","volume":"72","author":"Dale","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-3476(96)70443-2","article-title":"A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life","volume":"128","author":"Rosenthal","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0165","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bmt.1705508","article-title":"The use of granulocyte colony-stimulating factor in volunteer blood and marrow registry donors","volume":"38","author":"Pamphilon","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0170","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1182\/blood-2007-07-097543","article-title":"Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges","volume":"111","author":"Anderlini","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06524.x","article-title":"Long-term safety of filgrastim (rhG-CSF) administration","volume":"137","author":"Confer","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-3148.1994.tb00258.x","article-title":"Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation. Prepared by the BCSH Blood Transfusion Task Force","volume":"4","year":"1994","journal-title":"Transfus Med"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0185","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1460-9592.2010.03366.x","article-title":"Risk in pediatric anesthesia","volume":"21","author":"Paterson","year":"2011","journal-title":"Paediatr Anaesth"},{"issue":"4","key":"10.1016\/j.bbmt.2017.12.786_bib0190","article-title":"Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults","author":"Holtick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bmt.2008.335","article-title":"Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study","volume":"43","author":"Leitner","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.12.786_bib0200","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbmt.2015.01.021","article-title":"Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age","volume":"21","author":"Martino","year":"2015","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117317184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117317184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:02:54Z","timestamp":1761058974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117317184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1083879117317184"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.12.786","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.12.786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}